Source:http://linkedlifedata.com/resource/pubmed/id/17891924
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0007584,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0034760,
umls-concept:C0039194,
umls-concept:C0085550,
umls-concept:C0301630,
umls-concept:C0332161,
umls-concept:C0449445,
umls-concept:C0806140,
umls-concept:C0814423,
umls-concept:C1273870,
umls-concept:C1332714
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-9-25
|
pubmed:abstractText |
In Thailand, the cost of antiretrovirals has recently been reduced more than 10 fold. Likewise strategies for a cost reduction in laboratory monitoring are warranted. This study was designed to explore if the most expensive reagent in flow cytometry based CD4+ cell monitoring, the CD4+/CD8+ monoclonal antibodies, can be reduced without a loss of accuracy. Blood samples from 55 HIV seronegative (HIV-) and 76 HIV+ subjects were analyzed for %CD4+ and %CD8+ T cells using a two color monoclonal antibody panel (BD Biosciences, CA, USA) with 3 different amounts of the recommended reagents for staining: 1) standard, 2) half, and 3) one-fourth. A significant Spearman correlation of 0.987 was shown for the % CD4+ T cell test results for one half as well as one-fourth of the recommended amount compared to the standard staining according to the manufacturer's instruction (p < 0.0001). For the % CD8+ T cell test results, the correlation between the standard and the half or one-fourth reduced staining was 0.972 (p < 0.0001). Bland-Altman analysis showed no significant bias between the results from one half or one-fourth of the recommended amount versus the standard. The sensitivity and specificity of the two methods at the CD4+ T cell count cut-off of 200 cells/microl were 93% and 100%; and 96% and 99%, respectively. Our study indicates that a reduction of the reagents to half or one-fourth of the amount recommended by the manufacturer was still able to generate reliable results for CD4+ and CD8+ T cell counts. Such an approach will significantly reduce the cost of CD4+ monitoring for resource limited settings where a flow cytometer is available.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0125-877X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-9
|
pubmed:meshHeading |
pubmed-meshheading:17891924-CD4 Lymphocyte Count,
pubmed-meshheading:17891924-Cost Savings,
pubmed-meshheading:17891924-Flow Cytometry,
pubmed-meshheading:17891924-HIV Infections,
pubmed-meshheading:17891924-Humans,
pubmed-meshheading:17891924-Sensitivity and Specificity,
pubmed-meshheading:17891924-Thailand
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cost savings by reagent reduction in flow cytometry-based CD4+ T cell counts: an approach to improve accessibility for HIV management.
|
pubmed:affiliation |
Division of Allergy and Clinical Immunology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand.
|
pubmed:publicationType |
Journal Article
|